BPOM Generalized Sirop Praxion Drug Safe Consumpted

Screenshot of Plt. Deputy for Drug Control, Narcotics, Psychotropics, Precursors, and Addictive Substances of BPOM Togi Junice Hutadjulu/ANTARA

JAKARTA - The Food and Drug Supervisory Agency (BPOM) announced that the Praxion▁Sedangkand drug is safe for consumption based on a series of tests that have been carried out using seven samples with eligible results. "From the results of the testing of the seven samples, the results are eligible. This means that they meet the provisions and standards in Indonesian pharmacopies," said Plt. Deputy for Drug, Narcotics, Psychotropics, Precursors, and Addictive Substances of BPOM Togi Junice Hutadjulu in Jakarta, Antara, Wednesday, February 8. Togi explained that the seven samples tested were sampled with medicinal supplements and raw materials, consisting of a sample of cirrup drugs left by patients, sirops circulating on the market, samples at the production site with the same batch, and sirop samples with batches adjacent to patient drug sirops. Then samples of soorbitol raw materials, and two other sirop products that use raw materials with the same batch number. He emphasized that testing samples in the BPOM National Food and Drug Testing Center (PPPOMN) laboratory had met the standards of the World Health Organization (WHO) so that its accuracy could be ascertained. The tests were carried out on February 2 and 3, 2023. "The test results can be believed to have validity to support the results of BPOM's supervision," he said. He further said that BPOM had ordered a temporary suspension of the production and distribution of drugs consumed by patients who were confirmed to have died due to Atypical Progressive Acutement Disorder (GGAPA) on February 4, 2023. Based on information that ANTARA received, one case was a toddler who died after taking the Praxion brand of sirop drug in DKI Jakarta. "In order to be careful and take anticipatory steps, BPOM has issued an order to temporarily suspend the production and distribution of drugs consumed by patients," he said. Togi added that BPOM continues to coordinate with related parties such as the Ministry of Health, DKI Jakarta Health Service, DKI Jakarta Regional Health Laboratory, Indonesian Pediatrician Association, epidemiologists and pharmacologists to investigate the cause of death of the toddler. BPOM also appealed to the public to be vigilant and to continue to be careful to buy and take drugs. "This step was taken to determine the causes and risk factors that caused GGAPA," said Togi Junice ending his explanation.